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Abstract Proteinase-activated receptor-2 (PAR-2) is a member
of a family of G-protein-coupled, seven-transmembrane domain
receptors that are activated by proteolytic cleavage. The receptor
is expressed in a number of different tissues and potential
physiological activators identified thus far include trypsin and
mast cell tryptase. Acrosin, a trypsin-like serine proteinase found
in spermatozoa of all mammals, was found to cleave a model
peptide fluorescent quenched substrate representing the cleavage
site of PAR-2. This substrate was cleaved with kinetics similar to
those of the known PAR-2 activators, trypsin and mast cell
tryptase. Acrosin was also shown to induce significant intracel-
lular calcium responses in Chinese hamster ovary cells stably
expressing intact human PAR-2, most probably due to activation
of the receptor. Immunohistochemical studies using PAR-2
specific antibodies indicated that the receptor is expressed by
mouse oocytes, which suggests that acrosin may play additional
role(s) in the fertilization process via the activation of PAR-2 on
oocytes. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Proteinase-activated receptor-2 (PAR-2) is the second mem-
ber of the growing family of proteolytically activated recep-
tors, which couple to G-proteins to produce intracellular re-
sponses [1^6]. Proteolytic cleavage of the extracellular domain
of PAR-2 reveals a new amino-terminus which acts as a
‘tethered ligand’ to cause receptor activation. PAR-2 is ex-
pressed in a number of tissues, including the gastrointestinal
and respiratory tracts, pancreas, kidney, liver, ovary, bone
and skin, and is found in epithelial and endothelial cell lines,
smooth muscle, T cell lines, neutrophils, osteoblasts and cer-
tain tumor cell lines [1^15]. Trypsin appears to activate PAR-2
under physiological conditions in the gastrointestinal and
respiratory tracts [16,17], while tryptase may be important
in pathological conditions involving mast cell in¢ltration
and/or degranulation [18]. A synthetic receptor agonist pep-
tide (RAP) corresponding to the tethered ligand is also able
to activate the receptor [19]. However, activators in many
of the tissues where PAR-2 is found have still not been iden-
ti¢ed and most known proteinases apart from trypsin and
tryptase do not activate the receptor, hence knowledge of
the physiological and pathological roles of receptor activation
is limited.
Trypsin, tryptase and the sperm protease, acrosin, were
identi¢ed as potential physiological PAR-2 activators by
Fox et al. [20] using a four amino acid chloromethyl ketone
inhibitor. Due to the fact that proteolytic speci¢city depends
on the amino acid sequence on both sides of the cleavage site,
we have developed a £uorescent quenched substrate (FQS)
containing both the amino acids prior to and after the cleav-
age site of PAR-2 (residues 33^41 of human PAR-2). The
peptide substrate is based on the principle whereby an amino-
benzoic (Abz) acid £uorescent group on the substrate is
quenched by a dinitrophenol (Dnp) group attached to the
opposite end of the peptide. Cleavage of the peptide then
removes the quenching group, allowing the cleaved substrate
to £uoresce. Potential activators of PAR-2 must be trypsin-
like enzymes capable of cleaving at the Arg36^Ser37 bond
within the PAR-2 extracellular domain (Ser33-Lys-Gly-Arg-
Ser-Leu-Ile-Gly40).
Acrosin, a trypsin-like serine proteinase found in large
quantities in the acrosomal body of spermatozoa of all mam-
mals [21,22], has been suggested to have several functions
during fertilization, most notably to facilitate sperm penetra-
tion through the zona pellucida, as a secondary binding pro-
tein and in dispersal of the acrosomal contents [23^25]. Acro-
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sin has also been found on the inner acrosomal membrane of
spermatozoa in the perivitilline space where it may have a role
in membrane fusion [26].
In this report we demonstrate the utility and speci¢city of
our FQS to assay acrosin and other proteases for their poten-
tial to activate PAR-2. Evidence is provided that acrosin
causes PAR-2-mediated intracellular Ca2 mobilization in
Chinese hamster ovary (CHO) cells expressing PAR-2 and
that mouse oocytes express PAR-2.
2. Materials and methods
2.1. Materials
Tissue culture media and media supplements were purchased from
Trace Biosciences (Sydney, Australia). Non-enzymic dissociation so-
lution and bovine serum albumin (BSA) were purchased from Sigma
(Sydney, Australia). The antibiotic G-418 sulfate was obtained from
Gibco-Life Technologies (Melbourne, Australia) and Fura-2-acetoxy-
methyl ester (Fura-2/AM) was obtained from Molecular Probes (Eu-
gene, OR, USA). All other chemicals used were of the highest grade
commercially available.
The synthetic peptide, Abz-Ser-Lys-Gly-Arg-Ser-Leu-Ile-Gly-
Lys(Dnp)-Asp-OH was synthesized as previously described [27]. Acro-
sin from boar sperm was puri¢ed as described [28]; recombinant hu-
man mast cell skin tryptase I was puri¢ed as previously described [29]
and human thrombin and factor Xa were obtained from Wei Wen
Dai (Department of Biochemistry and Molecular Biology, Monash
University). The synthetic human PAR-2 agonist peptide, H-
SLIGKV-NH2 (RAP) was synthesized by Auspep Pty. Ltd. (Parkville,
Australia). Human plasmin, urokinase, activated protein C (APC),
kallikrein and bovine trypsin were purchased from Sigma (Sydney,
Australia). Two di¡erent anti-mouse PAR-2 antibodies (PAR-2A
and PAR-2B), which have been extensively characterized as being
speci¢c for PAR-2, were used for immunohistochemistry. Both anti-
bodies were prepared in rabbits immunized with synthetic peptides
corresponding to the tethered ligand region of mouse PAR-2. PAR-
2A [30] was kindly provided by COR Therapeutics and PAR-2B [15]
by the late Prof. Stuart Stone.
2.2. Generation of CHO transfectants expressing PAR-2
Brie£y, CHO cells were co-transfected using calcium phosphate
with pSV2Neo and either pBJ vector [31] or pBJ vector containing
the human PAR-2 full-length coding sequence. Cells were selected
with the antibiotic G-418 sulfate for neomycin resistance and individ-
ual colonies were isolated by repeated rounds of limited dilution.
Single cell clones expressing high levels of PAR-2 were selected by
£ow cytometry using S14.8.2, a monoclonal antibody speci¢c to the
N-terminus of human PAR-2. PAR-2 clones were then screened for
high levels of activity using arachidonate release [32] in response to
trypsin as a measure of activity.
2.3. Enzyme assays and measurements of kinetic constants
All experiments were performed at 37‡C in appropriate assay bu¡-
ers. Assays using acrosin, plasmin, urokinase, APC, factor Xa and
kallikrein were performed in 50 mM Tris^HCl (pH 7.4), 1 mM CaCl2,
0.02% (w/v) NaN3. Speci¢c assay bu¡ers were used for the following
enzymes: trypsin ^ 0.1 M HEPES (pH 7.4), 0.1 M NaCl, 10 mM
CaCl2, 0.1% (w/v) PEG (8000), 0.02% (w/v) NaN3 ; thrombin ^ 50
mM Tris^HCl (pH 7.4), 10 mM NaCl, 0.2% (w/v) PEG (8000), 0.02%
(w/v) NaN3 ; and tryptase ^ 0.1 M HEPES (pH 7.5), 10% glycerol
(v/v), 10 WM heparin, 0.05% (v/v) brij-35, 0.02% (w/v) NaN3. The
substrate solution (0.5 ml) was equilibrated to 37‡C for 10 min and
the enzyme solution added. Enzyme activity was monitored by con-
tinuously measuring the £uorescence (Vex = 330 nm; Vem = 440 nm)
using a Molecular Dynamics BioLumin 960 Microassay Reader
(Pharmacia Biotech, Australia) [33].
Lyophilized PAR-2 peptides were resuspended in dimethylforma-
mide and the concentration of stock solutions determined spectropho-
tometrically, where the absorption coe⁄cient was assumed to be
104 M31 cm31 at 360 nm [33]. Fluorescence of peptide products after
exhaustive cleavage by trypsin was found to be proportional to con-
centration. Accordingly, an increase in £uorescence corresponds to an
increase in concentration of cleaved peptide. Therefore, from an anal-
ysis of initial velocities obtained at di¡erent substrate concentrations,
the kinetic parameters, Km and kcat were determined.
2.4. Cells and culture conditions
The transfected CHO cell line stably expressing PAR-2 and the
non-transfected cell line were cultivated in Dulbecco’s modi¢ed Eagle
medium: Hams F-12 (1:1; pH 7.4) containing L-glutamine (200 mM),
10% (v/v) fetal bovine serum, penicillin/streptomycin (5000 U/ml),
NaHCO3 (1.2 g/l) and the selective agent, antibiotic G-418 sulfate
(0.565 g/l). They were grown as monolayer cultures (in £asks up to
175 cm2) under a 5% CO2 atmosphere of 100% humidity at 37‡C.
2.5. Measurement of intracellular calcium ([Ca2+]i) responses in
CHO cells
Cells grown to 80% con£uence were washed with phosphate-bu¡-
ered saline (PBS) and removed from the £asks using non-enzymatic
dissociation solution and prepared for [Ca2]i measurements essen-
tially according to published methods [34]. Cells were resuspended
at a concentration of 10U106 cells/ml in extracellular medium (EM;
121 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2W6H2O, 1.8 mM CaCl2,
5.5 mM glucose, 25 mM HEPES (pH 7.4)) containing 0.2% (w/v)
BSA.
The CHO cells were loaded with the £uorescent indicator Fura-2/
AM at room temperature as previously described [34]. Cells were
centrifuged prior to £uorescence measurements and resuspended in
EM (without BSA) at a concentration of 2U106 cells/ml for £uores-
cence measurements in stirred cuvettes. The ratio of the Fura-2/AM
£uorescence at 510 nm after excitation at 340 and 380 nm was moni-
tored using a Perkin-Elmer LS-50B spectro£uorimeter. After initial
baseline recording, proteinases (trypsin and acrosin) and receptor ag-
onist, RAP, were added to the cells and the ratio of the £uorescence at
the two excitation wavelengths, which is proportional to the [Ca2]i,
was measured.
2.6. Immunohistochemistry
Ovaries removed from 16 week old mice were prepared for immu-
nohistochemistry and stained according to methods employed by
Abraham et al. [15]. Brie£y, the ovaries were ¢xed in paraformalde-
hyde (4% (w/v) in PBS), cryoprotected in sucrose (25% (w/v) in PBS)
and embedded in Tissue-Tek OCT compound. Serial cryosections
(10 Wm) were treated with 0.3% (w/v) hydrogen peroxide in methanol
to quench endogenous peroxidase activity. PAR-2A (1:1000), PAR-
2B (2.5 Wg/ml) or normal rabbit serum (1:1000) were diluted in PBS
containing 0.1% (w/v) BSA, applied to sections and then detected
using the avidin^biotin^peroxidase complex system (Immunopure,
ABC Peroxidase Staining kit, Pierce, Rockford, USA) and 3,3P-dia-
minobenzidine peroxidase substrate (Sigma, Sydney, Australia), ac-
cording to the manufacturers’ instructions. The sections were counter-
stained with hematoxylin, dehydrated, mounted and examined with a
light microscope.
3. Results and discussion
The PAR-2 £uorescent quenched peptide substrate, Abz-
Ser-Lys-Gly-Arg-Ser-Leu-Ile-Gly-Lys(Dnp)-Asp-OH, was
¢rstly evaluated for its accuracy as a predictor of receptor
cleavage. The Abz group only £uoresces when the quenching
group Lys(Dnp) is released upon proteolytic cleavage. There-
fore, activators of PAR-2 would be predicted to hydrolyze the
Table 1
Kinetic parameters of the cleavage of a synthetic peptide corre-
sponding to the activation sequence of PAR-2
Enzyme Km (WM) kcat (s31) kcat/Km (WM s31)
Trypsin 13.5 372.0 27.6
Tryptase 29.1 426.0 14.6
Acrosin 22.0 320.0 14.6
Thrombin, plasmin, urokinase, APC, kallikrein and factor Xa were
unable to cleave the substrate at concentrations up to 100 nM. The
standard error of the mean for each derived kinetic constant was al-
ways below 10%.
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synthetic peptide, while non-activators would be incapable of
doing so. In order to test this system, the kinetics of cleavage
of the peptide with known activators of PAR-2 (trypsin, tryp-
tase), as well as known non-activators (thrombin, plasmin,
urokinase, APC, kallikrein) were investigated. It was found
that trypsin could cleave the substrate at a concentration as
low as 0.1 nM, and tryptase as low as 10 nM, while thrombin
and the other known non-activators were unable to cleave the
substrate at signi¢cantly higher levels (up to 100 nM). Trypsin
and tryptase e⁄ciently cleaved the substrate as exhibited by
the high kcat/Km values (Table 1), consistent with the knowl-
edge that these two proteases are known activators of PAR-2
[1^18]. Additionally, heat-inactivated trypsin and tryptase
were unable to cleave the substrate, demonstrating that the
cleavage e¡ect shown by the proteases is due to enzymatic
activity. The cleavage of the PAR-2 substrate by trypsin and
tryptase, but not the non-activators, supports the hypothesis
that the peptide may be considered as an e¡ective model for
determining the potential of a given proteinase to activate the
receptor.
Having established the FQS as a suitable model for the
PAR-2 cleavage site, we went on to investigate the ability of
two proteinases (factor Xa and acrosin), identi¢ed by Fox et
al. [20] as putative activators of PAR-2, to cleave the FQS.
Firstly, the ability of factor Xa to cleave PAR-2 has been the
subject of contradictory data. With regard to data derived
from interactions with peptides or peptide inhibitors contain-
ing the sequence of the activation site of PAR-2, it has been
suggested that factor Xa may be a PAR-2 activator, although
the interaction was not as strong as for known activators such
as trypsin or tryptase [20]. Molino et al. [18] showed that
factor Xa cleaved a synthetic peptide representing the activa-
tion site of the receptor weakly in comparison to trypsin or
tryptase. The studies we carried out with the FQS similarly
indicate that the enzyme does not activate PAR-2, which is
consistent with previous studies demonstrating that factor Xa
does not activate the receptor [35]. A recent study has now
shown that factor Xa can activate PAR-2 in vivo [36], how-
ever. Thus, while experiments with synthetic peptides repre-
senting the activation site of PAR-2 are instructive with re-
gard to the kinetics of cleavage of the sequence by a particular
protease, the results with factor Xa suggest that they are in-
terpreted with caution and need to be con¢rmed by studies
with the whole receptor in a cellular setting.
Acrosin was also investigated for its ability to cleave the
PAR-2 model substrate. It is known that, like trypsin, acrosin
cleaves after arginine or lysine residues, with preference for
arginine over lysine [21]. Considering this and previous inhi-
Fig. 1. The [Ca2]i response of PAR-2-transfected (A, B, C and E) and non-transfected CHO cells (D and F) in response to RAP, AEBSF-
treated acrosin (AEBSF-acrosin), trypsin, or acrosin.
FEBS 24250 6-11-00
R. Smith et al./FEBS Letters 484 (2000) 285^290 287
bition studies [20], the PAR-2 FQS was used to examine the
potential of acrosin to cleave PAR-2. Acrosin at concentra-
tions as low as 0.1 nM was found to cleave the substrate with
similar kinetics to trypsin and tryptase (Table 1), suggesting
that the enzyme is indeed a potential physiological PAR-2
activator.
Based on acrosin’s ability to hydrolyze the PAR-2 peptide,
we sought evidence that the proteinase may be able to cleave
within the intact receptor itself. This possibility was addressed
by monitoring the increase in intracellular calcium levels of
CHO cells stably expressing the intact human form of PAR-2.
Acrosin was applied to both the PAR-2-transfected and the
non-transfected cells and tested for a [Ca2]i response. Tryp-
sin, a well characterized activator of PAR-2, and the RAP
were also tested for a response on the cells. The transfected
cells showed an increase in [Ca2]i in response to RAP treat-
ment (Fig. 1A), whereas a response was not seen in the non-
transfected cells (data not shown). Both trypsin and acrosin
(Fig. 1C,E), at concentrations as low as 1 nM, were shown to
induce signi¢cant intracellular calcium responses in the PAR-
2-transfected CHO cells, whereas no response was observed in
the non-transfected cells at the same enzyme concentrations
(Fig. 1D,F). At concentrations higher than 4 nM acrosin or
1 nM trypsin, a response, although signi¢cantly smaller, was
observed in the non-transfected cells. This response was char-
acterized by a small and slowly developing elevation in cal-
cium concentration (also observed by Nystedt et al. [37] for
CHO cells), in contrast to the more rapid responses for the
transfected cells. These residual responses in the non-trans-
fected cells may be attributed to the presence of endogenous
PAR-2 on the surface of the cells. Additionally, acrosin inac-
tivated by the serine protease inhibitor 4-(2-aminoethyl)-ben-
zenesulfonyl £uoride (AEBSF) or by boiling was unable to
elicit a response in the transfected cells, with the cells showing
a normal response when subsequently challenged by trypsin
(Fig. 1B).
After adjusting for the small background responses seen in
the non-transfected cells, acrosin was found to induce a dose-
dependent increase in [Ca2]i in the transfected CHO cells.
The enzyme concentration inducing half the maximal response
(EC50) was 4.1 þ 0.34 nM (Fig. 2A), which is comparable to
the EC50 of trypsin on the transfected cells of 0.98 þ 0.09 nM
(Fig. 2B). These results indicate that acrosin is able to activate
PAR-2 on cell surfaces.
As proteinase-activated receptors are activated by irrevers-
ible cleavage of the extracellular domain, the receptors under-
go rapid desensitization after a short period of activation by
an enzyme agonist. Thus, it has been shown that a single
application of trypsin causes marked desensitization of
[Ca2]i responses (Fig. 3A). Considering this, studies were
Fig. 2. The [Ca2]i response of PAR-2-transfected CHO cells to di¡erent concentrations of acrosin (A) and trypsin (B). The [Ca2]i values for
each enzyme concentration represent the mean þ S.E.M. derived from three traces similar to those shown in Fig. 1; dose response curves for
the two enzymes were also conducted on non-transfected cells, and the low levels of background [Ca2]i values were subtracted from the corre-
sponding values for PAR-2-transfected cells to obtain the curves displayed here.
Fig. 3. The e¡ects of desensitization on [Ca2]i in PAR-2-transfected
CHO cells treated with trypsin and acrosin. The e¡ects of adding
(A) 10 nM trypsin followed by another dose of 10 nM trypsin;
(B) 6 nM acrosin followed by 10 nM trypsin; and (C) 10 nM tryp-
sin followed by 6 nM acrosin; were tested in CHO cells transfected
with human PAR-2.
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carried out using the [Ca2]i mobilization assay in order to
determine if acrosin and trypsin were activating the same re-
ceptor. Exposure of the transfected cells to a maximal con-
centration of trypsin (10 nM ^ see Fig. 2) desensitized the
[Ca2]i responses to a subsequent challenge by acrosin (Fig.
3B). When the PAR-2-transfected cells were activated ¢rstly
with a sub-maximal dose of acrosin, a secondary response to
trypsin was signi¢cantly reduced (Fig. 3C). These results
strongly suggest that trypsin and acrosin activate a common
receptor on the transfected cells, namely PAR-2.
The results obtained imply that acrosin is an activator of
PAR-2. In this respect, it is interesting to note that PAR-2
immunoreactivity has previously been detected in the female
reproductive tract, with PAR-2 being expressed in the follicle
epithelium, follicle smooth muscle and myo¢broblasts of the
human ovary [7]. Since expression of PAR-2 has not been
reported on oocytes, we sought to address this question via
immunohistochemical staining of mouse oocytes with anti-
bodies speci¢c for PAR-2. In Fig. 4, oocytes located within
the mouse ovary are shown to be speci¢cally stained by anti-
bodies to PAR-2. PAR-2 immunoreactivity was observed in
both the cytoplasm and plasma membrane of oocytes in pri-
mary, secondary and tertiary follicles.
The potential role of acrosin in the recognition, binding and
penetration of the zona pellucida by sperm has been well
documented [24,25]. Here we show that acrosin can induce
signi¢cant intracellular calcium responses on PAR-2-bearing
cells, and that the receptor is expressed by oocytes. These
observations suggest that acrosin is likely to activate PAR-2
on oocytes. Such activation processes may play a role in fer-
tilization by enhancing the fusigenicity of the oolemma for the
sperm’s plasma membrane, or initiating cortical granule exo-
cytosis and the block to polyspermy, or the activation of
calcium spiking within the egg cytoplasm which is required
for subsequent development [38^40].
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